Difference between revisions of "Minutes - Medication WG 2022-06-21"

From Health Level 7 Belgium Wiki
(Created page with "===== '''Attendees''' ===== * Annemieke Vergauwe * Bart Decuypere * Jean-Michel Polfliet * Jens Penny * José Costa Teixeira * Karlien Erauw * Pablo Christiaens * Tom He...")
 
 
Line 32: Line 32:
  
 
===== '''Minutes''' =====
 
===== '''Minutes''' =====
* Work on business rules is still ongoing at RIZIV end
+
* Can we propose a publication of the medication scheme consisting of treatment lines
* before we said that it has to be part of the implementation guide
+
::* Business rules of RIZIV are pending
 +
::* Examples are still missing
 +
* Advantage of publishing : reaching out to stakeholders (* although before we said that the business rules should be part of the implementation guide )
 +
::* Medication treatments & medication treatment lines
 +
::* Prescription system could start using the medication treatment
 +
* Medication statement : what is it ?
 +
::* Medication prescription
 +
::* Whenever you have a medication, you have a medication treatment
 +
::* How do we call it : medication line, medication statement line, medication treatment line ?
 +
 
 +
 
 
::* however, can we go and publish the medication scheme ?
 
::* however, can we go and publish the medication scheme ?
::* goal is for prescribor applications to start using the medication treatment
+
::* goal is for prescribor applications to start using the medication treatment  
 
+
::::* "The concept of "Medication Treatment Plan" of a patient represents the collection of all medication the patient was planned to take in the past, presently of in the future..."
* We need some documentation for the migration from Kmehr to FHIR: input is needed
+
::* and looking at scheme p16 at treatment plan
* We have to complexities of contraindications and (drug) allergies & intolerances
 
::* drug allergies & intolerances are related to decision support, therefore might not be needed to include in the medication scheme but offer as additional service
 
::* modelling of contraindications needs still to be determined, which can also be temporarily (f.e. pregnancy, breastfeeding)
 
::* allergy & intolerance will be the way to present this kind of info
 
::* there are 2 types for which distinction need to be made: patient related & drug related
 
::* patient's condition is part of medical history (f.e. epilepsy)
 
  
* SAM viewer, there is VNP, CNK etc
+
* Looking at [https://www.ihe.net/uploadedFiles/Documents/Pharmacy/IHE_Pharmacy_Suppl_MTP.pdf IHE Pharmacy supplement] for treatment definition
::* how many tables are there in the database ?
+
* We need to add a glossary on medication, José will start on it as google doc or github
::* this is the hierarchy: vmp-group > AMP > AMPP > CNK (old)
+
::* we also need an aggregated diagram incl. reconciliation of doctors
::* concepts to be uses in MS will have to be defined
 
::::* f.e. support substances ?
 
::::* Jens will have a look
 
  
 
'''Agenda items for next meeting'''
 
'''Agenda items for next meeting'''
 
* Current state of profiles on medication view and treatment lines and how it all works at operational level
 
* Current state of profiles on medication view and treatment lines and how it all works at operational level
* Review made changes
+
* Review glossary of terms &
 
* Collect feedback on contraindications
 
* Collect feedback on contraindications
 
* Identifying business rules  
 
* Identifying business rules  
  
'''Next meeting July 5 at 11AM'''
+
'''Next meeting July 12 at 11AM'''

Latest revision as of 10:02, 21 June 2022

Attendees
  • Annemieke Vergauwe
  • Bart Decuypere
  • Jean-Michel Polfliet
  • Jens Penny
  • José Costa Teixeira
  • Karlien Erauw
  • Pablo Christiaens
  • Tom Henkens
Excused/Not present
  • Anne Nerenhausen
  • Bruno Casneuf
  • Dieter Sauvillers
  • Elhassan Baazizi
  • Hanne Vuegen
  • Jan Lenie
  • Jean-Louis Maggetto
  • Katrien Thorré
  • Lars Vanreppelen
  • Marc Buckens
  • Nick Hermans
  • Nils Devos
  • Richard Francken
  • Thomas Van Langendonck
  • Tom De Backer
  • Walter Bollaert
  • Will van Norel
Agenda
  • Future of medication scheme
Minutes
  • Can we propose a publication of the medication scheme consisting of treatment lines
  • Business rules of RIZIV are pending
  • Examples are still missing
  • Advantage of publishing : reaching out to stakeholders (* although before we said that the business rules should be part of the implementation guide )
  • Medication treatments & medication treatment lines
  • Prescription system could start using the medication treatment
  • Medication statement : what is it ?
  • Medication prescription
  • Whenever you have a medication, you have a medication treatment
  • How do we call it : medication line, medication statement line, medication treatment line ?


  • however, can we go and publish the medication scheme ?
  • goal is for prescribor applications to start using the medication treatment
  • "The concept of "Medication Treatment Plan" of a patient represents the collection of all medication the patient was planned to take in the past, presently of in the future..."
  • and looking at scheme p16 at treatment plan
  • Looking at IHE Pharmacy supplement for treatment definition
  • We need to add a glossary on medication, José will start on it as google doc or github
  • we also need an aggregated diagram incl. reconciliation of doctors

Agenda items for next meeting

  • Current state of profiles on medication view and treatment lines and how it all works at operational level
  • Review glossary of terms &
  • Collect feedback on contraindications
  • Identifying business rules

Next meeting July 12 at 11AM